Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast CancerShaveta Vinayak, Melinda L. Telli, Sara M. Tolaney et al.|JAMA Oncology|2019Cited by 446
TOPACIO/Keynote-162: Niraparib + pembrolizumab in patients (pts) with metastatic triple-negative breast cancer (TNBC), a phase 2 trial.Shaveta Vinayak, Melinda L. Telli, Sara M. Tolaney et al.|Journal of Clinical Oncology|2018Cited by 77
Immunomodulatory effects of vitamin D: implications for GVHDJacalyn Rosenblatt, David Avigan, Adam Bissonnette et al.|Bone Marrow Transplantation|2010Cited by 43
Generation of Tumor-specific T Lymphocytes Using Dendritic Cell/Tumor Fusions and Anti-CD3/CD28Jacalyn Rosenblatt, David Avigan, Thea M. Friedman et al.|Journal of Immunotherapy|2010Cited by 26
Immunomodulatory Effects Of Vitamin D: Implications For The Treatment Of Graft Versus Host DiseaseJacalyn Rosenblatt, David Avigan, Adam Bissonnette et al.|Transplantation and Cellular Therapy|2009Cited by 2